Pretax profits rise at Genzyme’s Irish business to €87m
Pharma giant’s revenues increase to €1.2bn due to product mix and transfer prices across group
Genzyme
Latest news about Genzyme
Genzyme Ireland sees 50% growth in profits to €65.2m
Numbers employed at the pharma firm last year continued to grow from 714 to 773
Life science sector gets the lion’s share of €96.2m IDA grants
Eight out of top 10 recipients were in life science sector, reflecting strong jobs growth
Sanofi confident for 2019 despite Q3 sales slip
Sales at the drugmaker’s vaccines unit down 9.8% over delay in WHO’s choice of flu inoculation
Sanofi targets profit growth from new drug push, reorganisation
Company is pinning hopes on new blood disorder treatment
Decision Time: What is the ideal postgraduate course for you?
Ensuring that your course of choice has credibility in the labour market a big challenge
Better financial and employment prospects for postgrads
Research shows higher levels of education increase your employability as well as salary
Actelion shares gain on report of progress in Sanofi talks
Share price had fallen by 7% recently as possible takeover of the firm failed to emerge
Sanofi hunts acquisition as profit dips 8.7%
French pharma firm courts cancer group Medivation as key drugs face generics
Sanofi to add up to 40 jobs at Waterford plant
Genzyme Waterford to be renamed Sanofi Waterford next month
CAO countdown: ‘Things have picked up’ in construction
Trainee plumber looks forward to working in a rapidly expanding sector
Postgraduate options: Moving up a level to master the job market
Research shows that advanced degree holders are more employable and earn higher salaries
It’s good to be green
Small changes saved big money in a Dublin fire station showing how green principles pay off
Companies harness environment to help workers smell the roses
Biophilic design seeks to bridge divide between natural and built environments
Drug firm may invest up to €1bn in Waterford
IDA holding advanced talks with major international pharmaceutical company
Sanofi’s Lemtrada fails to win FDA approval
Sanofi disagrees with the conclusion and said it will appeal
Whistle while you work
Savvy employers are realising that happy staff are more productive. Some firms now offer advice on health, money and even love
Elan battle intensifies as Royalty Pharma raises offer by 5 per cent
Tysabri manufacturer’s shares rise 5.3 per cent
Shareholders support Elan buyback programme
Royalty Pharma said to be considering bonus payments based on Tysabri sales
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices